KMT2A and acute myeloid leukemia: Our observations are reminiscent of a phenomenon described in a recent study based on a DNA NGS analysis of KMT2A-PTDs, showing a progressive increase in the complexity and copy number of KMT2A-PTD variants with time, notably during the progression from MDS to AML [18].